SanDiego, CA, – Solulink, Inc., an emerging life science tools company with expertise in biomolecularlinking,today announced John L. “Kip” Miller hasjoined the company’s Board ofDirectors.

The addition of Mr. Millerto the Solulink board will be instrumental asthe company commences commercialization fitsHybriLink™ technology. TheHybriLink technology solvesthe ‘missing color’ problem:the inability to find the needed antibody labeled with the rightfluorophore (color). Often,the desired combination is not commercially available.

By providing a simple way tomix andmatch any fluorophore with any antibody on demand, just?in?time atthe point?of?use,HybriLink dramatically streamlinesthe development and expansion ofmulticolor flow panelsforflow cytometry research labs. Solulink believesthatHybriLink’s ability to offer all antibodiesin allfluorophores – including the next generation of emerging fluorophores – resolves a fundamental challenge in flow cytometry and will expand the overallflow cytometry reagentsmarket size.

Mr. Miller brings a solid track record of life science leadership with a strong background in commercial operations, and extensive experience in the life science research and diagnosticmarkets. Mostrecently, Mr. Millerserved as President ofGenetic Systems at Life Technologies. From2008 to 2011, he served as Senior Vice President of Biodiscovery atInvitrogen Corporation, whichmerged with Applied Biosystems in 2008 to formLife Technologies. Priorto joining Invitrogen Corporation, Mr. Millerserved in various capacitiesfor BDincluding VPGM of BD Biosciences Research Cell Analysis Business, VPGM of BD

Pharmingen and VP Sales and Service the Americas’. Mr. Miller holds a B.S. in Packaging Engineering from Michigan StateUniversity.

Currently, Mr. Milleris a co?founder andmember ofthe Board of Directors at Tonbo Biosciences, and a member ofthe Board ofDirectors at Firefly BioWorks.

“We are delighted to welcome Kip to the Solulink board, and excited by the prospect of working with this dynamic leaderto advance Solulink’s new HybriLink technology,” said Walt Young, Solulink’sChairman ofthe Board. “Kip’s perspective and expertise will be invaluable as Solulink pursuesits new HybriLink productsforflow cytometry and implementstheir commercialization strategy.”

About Solulink

Solulink, a privately?held life science tools company, develops,manufactures andmarkets proprietary, next generation linking technology forthe development and improvement of productsin the research assay and diagnosticmarkets. Solulink’slatestinnovation,theHybriLink Technology, improvesthe capabilities of end users, developers and suppliersto utilize the growing wide variety of detection technologiesforresearch and diagnostic life science assays. Solulinkmarketstheir products directly and through distributors and licensing partners world?wide.